Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sagimet Biosciences Inc.
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
May 23, 2026
Sagimet Biosciences Provides Strategic and Corporate Updates
May 23, 2026
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
May 22, 2026
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2026
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
May 16, 2026
←
Previous Page
1
2